HopeStage
Back to all studies
CompletedNCT00611806

Folate and vitamin B12 or placebo for negative symptoms in schizophrenia

About this titleRead the official source — NCT00611806
Placebo comparisonAges 18–68United States
The study in practice

Understand this study

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 68 years. Other eligibility criteria applied.

Listed locations
Boston and 2 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateDecember 2007
Recruitment status
Completed
Enrollment listed in the registry
140
Sponsor
Massachusetts General Hospital
Sponsor type
Hospital / academic medical center
Study type
Other
Intervention type
Dietary supplement, Other
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 68 Years
Official registry ID
NCT00611806
Official title
Show the full official title

A Placebo-Controlled Trial of Folate With B12 in Schizophrenia Patients With Residual Symptoms

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Boston · Grand Rapids · Rochester

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 68 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies